Live
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
CNBC · Center
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Read the full story at the original publisher
CNBC →
-
Amelia Earhart mystery continues after search based on ‘satellite photo of plane’The Independent World Leans Left3 days ago
-
Republican candidate forced out of race after suspected drunk driving crash leaves car overturnedThe Independent World Leans Left3 days ago
-
Democrat who told Susan Collins to ‘shut up’ doubles down and refuses to apologizeThe Independent World Leans Left3 days ago
Leave a Reply